Despite Global Crisis, China’s Strongest Pharma Firms Likely To Thrive In 2009 Through Innovation And Acquisitions
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Despite the Western world's financial meltdown and China's own faltering economic growth rates, the country's leading pharmaceutical companies are forecast to expand through 2009 by developing innovative drugs and by outlasting or even merging with their weakest competitors